Probiotic study seeks to uncover Microbiome's role in breast cancer
NCT ID NCT04362826
First seen Sep 30, 2025 · Last updated May 21, 2026 · Updated 31 times
Summary
This study is testing whether a probiotic supplement called BIOHM can change the bacteria and fungi living in the breast tumors and guts of 100 women with breast cancer. The goal is to understand how these tiny organisms might affect cancer development. Participants will take either the probiotic or a placebo for a period, and researchers will measure changes in their microbiome.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center
RECRUITINGCleveland, Ohio, 44122, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.